The Blog
-
Sep 06, 2024
ARV-766: A Promising PROTAC for Overcoming Resistance in Advanced Prostate Cancer
READ MORE -
Apr 30, 2024
Advances in FGFR: Cancer targets, therapy, and signaling elucidation
READ MORE -
Apr 29, 2024
Extracellular Protein Targeted Degradation (eTPD): Six Major Drug Discovery Patterns
READ MORE -
Apr 12, 2024
Discovery of target drugs
READ MORE -
Oct 12, 2023
New Opportunities for PROTAC
READ MORE -
Sep 22, 2023
Advancements and Opportunities in Targeted Protein Degradation: Unveiling Novel Therapeutic Pathways
READ MORE -
Sep 15, 2023
What is the future of small molecule drugs?
READ MORE -
Jun 08, 2023
PROTAC Design Guide: Synthesis Strategy for VHL PROTAC Linker
READ MORE -
UncategorizedMar 31, 2023
The status and challenges of thalidomide and its analogues
READ MORE